Autoimmune disease impacts 50 million Americans. AARDA is using a collective voice to raise awareness, advocate for patients and researchers and take action to ensure access to care.
Vanderbilt Children's Hospital researchers play key role in groundbreaking study.
On Sept. 28, the U.S. Food and Drug Administration approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: